Pathological implications of iNOS expression in central white matter: An ex vivo study of optic nerves from rats with experimental allergic encephalomyelitis

European Journal of Neuroscience

Volumn 21, Issue 8, 2005, Pages 2127-2135

  Garthwaite, G ^a   Batchelor, A M ^a   Goodwin, D A ^a,c   Hewson, A K ^b   Leeming, K ^a   Ahmed, Z ^b   Cuzner, M L ^b   Garthwaite, J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Axon; cGMP; Multiple sclerosis; Nitric oxide

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALIBRATION; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EX VIVO STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOPATHOLOGY; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE FIBER; NONHUMAN; OPTIC CHIASM; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WHITE MATTER;

1-METHYL-3-ISOBUTYLXANTHINE; ACTION POTENTIALS; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD2; ARGININE; BIOLOGICAL MARKERS; CYCLIC GMP; DEET; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GUANYLATE CYCLASE; GUINEA PIGS; HYDRAZINES; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN BASIC PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OPTIC CHIASM; OPTIC NERVE; ORNITHINE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, INBRED LEW; TIME FACTORS;

EID: 18844412127     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04062.x     Document Type: Article

References (49)

1. Alderton, W.K., Cooper, C.E. & Knowles, R.G. (2001) Nitric oxide synthases: structure, function and inhibition. Biochem. J., 357, 593-615.
2. Bal-Price, A. & Brown, G.C. (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci., 21, 6480-6491.
3. Beckman, J.S. & Koppenol, W.H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol., 271, C1424-C1437.
4. Bellamy, T.C., Griffiths, C. & Garthwaite, J. (2002) Differential sensitivity of guanylyl cyclase and mitochondrial respiration to nitric oxide measured using clamped concentrations. J. Biol. Chem., 277, 31801-31807.
5. Bellamy, T.C., Wood, J., Goodwin, D.A. & Garthwaite, J. (2000) Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl Acad. Sci. USA, 97, 2928-2933.
6. Bjartmar, C., Wujek, J.R. & Trapp, B.D. (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci., 206, 165-171.
7. Brown, G.C. & Bal-Price, A. (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol. Neurobiol., 27, 325-355.
8. Brown, G.C. & Cooper, C.E. (1994) Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett., 356, 295-298.
9. Bunn, S.J., Garthwaite, J. & Wilkin, G.P. (1986) Guanylate cyclase activities in enriched preparations of neurones, astroglia and a synaptic complex isolated from rat cerebellum. Neurochem. Int., 8, 179-185.
10. Chan, J.W. (2002) Optic neuritis in multiple sclerosis. Ocul. Immunol. Inflamm., 10, 161-186.
11. Compston, A. (2004) The marvellous harmony of the nervous system: the origins of multiple sclerosis. Clin. Med., 4, 346-354.
12. Cross, A.H., Manning, P.T., Stem, M.K. & Misko, T.P. (1997) Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J. Neuroimmunol., 80, 121-130.
13. Ferguson, B., Matyszak, M.K., Esiri, M.M. & Perry, V.H. (1997) Axonal damage in acute multiple sclerosis lesions. Brain, 120, 393-399.
14. Friebe, A. & Koesling, D. (2003) Regulation of nitric oxide-sensitive guanylyl cyclase. Circ. Res., 93, 96-105.
15. Garthwaite, G., Brown, G., Batchelor, A.M., Goodwin, D.A. & Garthwaite, J. (1999a) Mechanisms of ischaemic damage to central white matter axons: a quantitative histological analysis using rat optic nerve. Neuroscience, 94, 1219-1230.
16. Garthwaite, G., Goodwin, D.A., Batchelor, A.M., Leeming, K. & Garthwaite, J. (2002) Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience, 109, 145-155.
17. Garthwaite, G., Goodwin, D.A. & Garthwaite, J. (1999b) Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability. Eur. J. Neurosci., 11, 4367-4372.
18. Garvey, E.P., Oplinger, J.A., Furfine, E.S., Kiff, R.J., Laszlo, F., Whittle, B.J. & Knowles, R.G. (1997) 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol Chem., 272, 4959-4963.
19. Gibb, B.J., Wykes, V. & Garthwaite, J. (2003) Properties of NO-activated guanylyl cyclases expressed in cells. Br. J. Pharmacol., 139, 1032-1040.
20. Greenfield, D.S. (2002) Optic nerve and retinal nerve fiber layer analyzers in glaucoma. Curr. Opin. Ophthalmol., 13, 68-76.
21. Griffiths, C. & Garthwaite, J. (2001) The shaping of nitric oxide signals by a cellular sink. J. Physiol. (Lond.), 536, 855-862.
22. Griffiths, C., Wykes, V., Bellamy, T.C. & Garthwaite, J. (2003) A new and simple method for delivering clamped nitric oxide concentrations in the physiological range: application to activation of guanylyl cyclase-coupled nitric oxide receptors. Mol. Pharmacol., 64, 1349-1356.
23. Hall, C., Griffiths, C. & Garthwaite, J. (2003) Kinetics of nitric oxide inactivation in rat brain. J. Physiol. (Lond.), 547P, C36.
24. Hooper, D.C., Bagasra, O., Marini, J.C., Zborek, A., Ohnishi, S.T., Kean, R., Champion, J.M., Sarker, A.B., Bobroski, L., Farber, J.L., Akaike, T., Maeda, H. & Koprowski, H. (1997) Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl Acad. Sci. USA, 94, 2528-2533.
25. Hooper, D.C., Ohnishi, S.T., Kean, R., Numagami, Y., Dietzschold, B. & Koprowski, H. (1995) Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl Acad. Sci. USA, 92, 5312-5316.
26. Hu, P., Pollard, J., Hunt, N., Taylor, J. & Chan-Ling, T. (1998) Microvascular and cellular responses in the optic nerve of rats with acute experimental allergic encephalomyelitis (EAE). Brain Pathol, 8, 475-486.
27. Iadecola, C. (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci., 20, 132-139.
28. Kreutzberg, G.W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci., 19, 312-318.
29. Lassmann, H. (2003) Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J. Neurol. Sci., 206, 187-191.
30. Liu, X., Miller, M.J., Joshi, M.S., Sadowska-Krowicka, H., Clark, D.A. & Lancaster, J.R. Jr (1998) Diffusion-limited reaction of free nitric oxide with erythrocytes. J. Biol. Chem., 273, 18709-18713.
31. Liu, B. & Neufeld, A.H. (2000) Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia, 30, 178-186.
32. Liu, J.S., Zhao, M.L., Brosnan, C.F. & Lee, S.C. (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol., 158, 2057-2066.
33. McCall, T.B., Feelisch, M., Palmer, R.M. & Moncada, S. (1991) Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol., 102, 234-238.
34. Mo, E., Amin, H., Bianco, I.H. & Garthwaite, J. (2004) Kinetics of a cellular NO/cGMP/phosphodiesterase-5 pathway. J. Biol. Chem., 279, 26149-26158.
35. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T. & Sakoda, S. (1995) Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol., 62, 103-112.
36. Pedraza, C.E., Baltrons, M.A., Heneka, M.T. & Garcia, A. (2003) Interleukin-1 beta and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNA. J. Neuroimmunol., 144, 80-90.
37. Prineas, J.W. & Connell, F. (1978) The fine structure of chronically active multiple sclerosis plaques. Neurology, 28, 68-75.
38. Schmidt, K., Desch, W., Klatt, P., Kukovetz, W.R. & Mayer, B. (1997) Release of nitric oxide from donors with known half-life: a mathematical model for calculating nitric oxide concentrations in aerobic solutions. Naunyn Schmiedebergs Arch. Pharmacol., 355, 457-462.
39. Schopfer, F.J., Baker, P.R. & Freeman, B.A. (2003) NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem. Sci., 28, 646-654.
40. Smith, T., Hewson, A.K., Kingsley, C.I., Leonard, J.P. & Cuzner, M.L. (1997) Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am. J. Pathol., 150, 1909-1917.
41. Smith, K.J. & Lassmann, H. (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurol., 1, 232-241.
42. Stewart, V.C. & Heales, S.J. (2003) Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radic. Biol Med., 34, 287-303.
43. Stys, P.K. (1998) Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J. Cereb. Blood Flow Metab., 18, 2-25.
44. Stys, P.K., Ransom, B.R. & Waxman, S.G. (1991) Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis. Brain Res., 546, 18-32.
45. Villarroya, H., Klein, C., Thillaye-Goldenberg, B. & Eclancher, F. (2001) Distribution in ocular structures and optic pathways of immunocompetent and glial cells in an experimental allergic encephalomyelitis (EAE) relapsing model. J. Neurosci. Res., 63, 525-535.
46. Waxman, S.G. & Ritchie, J.M. (1993) Molecular dissection of the myelinated axon. Ann. Neurol., 33, 121-136.
47. Willenborg, D.O., Staykova, M.A. & Cowden, W.B. (1999) Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J. Neuroimmunol., 100, 21-35.
48. Wood, J. & Garthwaite, J. (1994) Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology, 33, 1235-1244.
49. Wykes, V. & Garthwaite, J. (2004) Membrane association and the sensitivity of guanylyl cyclase-coupled receptors to nitric oxide. Br. J. Pharmacol., 141, 1087-1090.